Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03 2024 - 7:00AM
Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ:
SHC), a leading global provider of mission-critical end-to-end
sterilization solutions, lab testing and advisory services for the
healthcare industry, today announced that Chairman and CEO Michael
B. Petras, Jr. will present at the 42nd Annual J.P. Morgan
Healthcare Conference on Tuesday, January 9, 2024 at 5:15 pm
Eastern. Mr. Petras, Jon Lyons, Senior Vice President and CFO, and
Jason Peterson, Vice President and Treasurer, will participate in
meetings with investors during the conference.
A live webcast of Mr. Petras’ presentation and accompanying
materials may be accessed via the Investor Relations section of the
Company’s website at Presentation & Events | Sotera Health. A
replay of the webcast will be archived on the Company's
website.
About Sotera Health:
Sotera Health Company is a leading global provider of
mission-critical end-to-end sterilization solutions and lab testing
and advisory services for the healthcare industry. Sotera Health
goes to market through three businesses – Sterigenics®, Nordion®
and Nelson Labs®. Sotera Health is committed to its mission,
Safeguarding Global Health®.
Updates can be found from time to time on recent developments in
matters relevant to investors on the Investor Relations section of
the Company’s website at Investor Relations | Sotera Health.
For developments related to Ethylene Oxide, updates can be found
at Ethylene Oxide | Sotera Health.
INVESTOR RELATIONS CONTACTS:
Jason PetersonVice President & Treasurer, Sotera
HealthIR@soterahealth.com
MEDIA CONTACT:
Kristin GibbsChief Marketing Officer, Sotera
Healthkgibbs@soterahealth.com
Source: Sotera Health Company
Sotera Health (NASDAQ:SHC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sotera Health (NASDAQ:SHC)
Historical Stock Chart
From Oct 2023 to Oct 2024